{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006281",
      "entity_text" : "DNA repair",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06118",
      "entity_text" : "PARP inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Ovarian cancer is commonly associated with homologous recombination (HR) deficiency resulting from BRCA1/2 (10-20% of high grade ovarian cancers) and BRCA like mutations (50% of high grade ovarian cancers) XREF_BIBR - XREF_BIBR, which make them sensitive to agents such as PARP inhibitors that prevent DNA repair XREF_BIBR.",
  "reading_complete" : "2020-08-03T17:32:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:30:33Z",
  "trigger" : "prevent",
  "evidence" : [ "PARP inhibitors that prevent DNA repair" ],
  "pmc_id" : "5957009",
  "score" : 0
}